Deep learning methods for drug response prediction in cancer: predominant and emerging trends
Not on the map. Why?
Abstract (arXiv)
Cancer claims millions of lives yearly worldwide. While many therapies have been made available in recent years, by in large cancer remains unsolved. Exploiting computational predictive models to study and treat cancer holds great promise in improving drug development and personalized design of treatment plans, ultimately suppressing tumors, alleviating suffering, and prolonging lives of patients. A wave of recent papers demonstrates promising results in predicting cancer response to drug treatments while utilizing deep learning methods. These papers investigate diverse data representations, neural network architectures, learning methodologies, and evaluations schemes. However, deciphering promising predominant and emerging trends is difficult due to the variety of explored methods and lack of standardized framework for comparing drug response prediction models. To obtain a comprehensive landscape of deep learning methods, we conducted an extensive search and analysis of deep learning models that predict the response to single drug treatments. A total of 60 deep learning-based models have been curated and summary plots were generated. Based on the analysis, observable patterns and prevalence of methods have been revealed. This review allows to better understand the current state of the field and identify major challenges and promising solution paths.
Key facts. Cited by 6 papers in the map (data through 14 Oct 2026). Builds on 30 of its 175 references that are in the map. First posted on arXiv 18 Nov 2022.
Builds on
30 of 175 references.
References · 30
- 2019PyTorch: An Imperative Style, High-Performance Deep Learning Librarycited by 20,305
- 2016Semi-Supervised Classification with Graph Convolutional Networkscited by 11,361
- 2017Graph Attention Networkscited by 8,923
- 2017A Unified Approach to Interpreting Model Predictionscited by 6,555
- 2017Inductive Representation Learning on Large Graphscited by 6,320
- 2017Axiomatic Attribution for Deep Networkscited by 3,384
- 2019Explainable Artificial Intelligence (XAI): Concepts, Taxonomies, Opportunities and Challenges toward Responsible AIcited by 1,552
- 2019A Comprehensive Survey on Transfer Learningcited by 1,160
- 2019Strategies for Pre-training Graph Neural Networkscited by 971
- 2018Junction Tree Variational Autoencoder for Molecular Graph Generationcited by 652
- 2019Interpretable machine learning: definitions, methods, and applicationscited by 305
- 2019Tackling Climate Change with Machine Learningcited by 265
18 more
- 2018Modeling polypharmacy side effects with graph convolutional networkscited by 237
- 20191D Convolutional Neural Networks and Applications: A Surveycited by 153
- 2022DataPerf: Benchmarks for Data-Centric AI Developmentcited by 90
- 2020Graph Neural Networks in TensorFlow and Keras with Spektralcited by 60
- 2017SMILES Enumeration as Data Augmentation for Neural Network Modeling of Moleculescited by 59
- 2021DGL-LifeSci: An Open-Source Toolkit for Deep Learning on Graphs in Life Sciencecited by 38
- 2016Removal of Batch Effects using Distribution-Matching Residual Networkscited by 18
- 2018Drug cell line interaction predictioncited by 8
- 2019Towards Explainable Anticancer Compound Sensitivity Prediction via Multimodal Attention-based Convolutional Encoderscited by 8
- 2020Ensemble Transfer Learning for the Prediction of Anti-Cancer Drug Responsecited by 6
- 2020Variational Autoencoder for Anti-Cancer Drug Response Predictioncited by 5
- 2018Predicting drug response of tumors from integrated genomic profiles by deep neural networkscited by 4
- 2020Learning Curves for Drug Response Prediction in Cancer Cell Linescited by 3
- 2021AGMI: Attention-Guided Multi-omics Integration for Drug Response Prediction with Graph Neural Networkscited by 3
- 2018PaccMann: Prediction of anticancer compound sensitivity with multi-modal attention-based neural networkscited by 2
- 2020A Systematic Approach to Featurization for Cancer Drug Sensitivity Predictions with Deep Learningcited by 2
- 2022Deep Surrogate Docking: Accelerating Automated Drug Discovery with Graph Neural Networkscited by 2
- 2021Deep Denerative Models for Drug Design and Responsecited by 1
Built on by
Citing papers per year: 2024: 2; 2025: 1; 2026: 3.
6 papers.
- 2024Assessing Reusability of Deep Learning-Based Monotherapy Drug Response Prediction Models Trained with Omics Datacited by 1
- 2025Benchmarking community drug response prediction models: datasets, models, tools, and metrics for cross-dataset generalization analysiscited by 1
- 2024Variational and Explanatory Neural Networks for Encoding Cancer Profiles and Predicting Drug Responsescited by 0
- 2026Sample-Efficient Adaptation of Drug-Response Models to Patient Tumors under Strong Biological Domain Shiftcited by 0
- 2026Large-scale AI-Ready Data for Anti-Cancer Drug Response Modelingcited by 0
- 2026PerturbRx: Learning Treatment-Conditioned Latent Transitions for Patient Drug Response Predictioncited by 0
- 2026PerturbRx: Learning Treatment-Conditioned Latent Transitions for Patient Drug Response Prediction21 Aug 2026
- 2026Large-scale AI-Ready Data for Anti-Cancer Drug Response Modeling11 Aug 2026
- 2026Sample-Efficient Adaptation of Drug-Response Models to Patient Tumors under Strong Biological Domain Shift17 Mar 2026
- 2025Benchmarking community drug response prediction models: datasets, models, tools, and metrics for cross-dataset generalization analysis18 Mar 2025
- 2024Assessing Reusability of Deep Learning-Based Monotherapy Drug Response Prediction Models Trained with Omics Data18 Sep 2024
- 2024Variational and Explanatory Neural Networks for Encoding Cancer Profiles and Predicting Drug Responses5 Jul 2024